Z-2743-2016 Class II Terminated
FDA device recall Z-2743-2016 was initiated by Integra LifeSciences Corp. on Jun 17, 2016 and is designated Class II. Reason for recall: Data from internal studies suggests there may be a potential that the secondary package seal integrity does not provide the level of sterility intended for Minimally Invasive Achilles Tendon Suture… The recall status is terminated (terminated Nov 7, 2017). Affected quantity: 6,729 units.
Recall details
- Product Type
- Devices
- Report Date
- Sep 14, 2016
- Initiation Date
- Jun 17, 2016
- Termination Date
- Nov 7, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 6,729 units
Product description
Achillon Minimally Invasive Device for Achilles Tendon Rupture Treatment The Achillon Suture System is a single use, sterile device used to treat acute Achilles tendon ruptures. The Achillon Suture System is a mini-invasive procedure indicated to teat acute Achilles tendon ruptures: Acute rupture of the Achill tendon(<10 days); Rupture located between 2 and 8 cm above calcaneum; Open or closed ruptures
Reason for recall
Data from internal studies suggests there may be a potential that the secondary package seal integrity does not provide the level of sterility intended for Minimally Invasive Achilles Tendon Suture System Achillon.
Distribution pattern
Nationwide distribution
Code information
Model #'s 19700 and 19700ND
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2743-2016
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026